• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Madrigal Pharmaceuticals Inc (NQ: MDGL )

    243.89 -2.11 (-0.86%)
    Streaming Delayed Price Updated: 4:00 PM EDT, Sep 6, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 222,463
    Open 249.62
    Bid (Size) 224.00 (4)
    Ask (Size) 268.00 (1)
    Prev. Close 246.00
    Today's Range 241.64 - 249.62
    52wk Range 119.76 - 299.98
    Shares Outstanding 17,103,395
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Is Madrigal Pharmaceuticals Stock a Buy?
    The biotech could be worth a lot more in 10 years. 
    Via The Motley Fool
    This 1 Setback for Novo Nordisk Is Bullish for Madrigal Pharmaceuticals Stock
    One player's minor pain is another's moderate gain. 
    Via The Motley Fool

    Performance

    YTD
    +7.51%
    +7.51%
    1 Month
    +0.10%
    +0.10%
    3 Month
    -4.31%
    -4.31%
    6 Month
    -6.25%
    -6.25%
    1 Year
    +24.07%
    +24.07%

    More News

    Read More
    10 Health Care Stocks With Whale Alerts In Today's Session
    Via Benzinga
    Biotech Stocks: Why Acadia Pharma And Others Are Feeling 'Growing Pains'
    Via Investor's Business Daily
    Topics Earnings
    Exposures Financial
    Is It Too Late to Buy Madrigal Pharmaceuticals Stock?
    Via The Motley Fool
    Is Madrigal Pharmaceuticals Stock a Buy?
    Via The Motley Fool
    7 Biotech Stocks to Keep on Your Clinical Radar
    Via InvestorPlace
    Is Madrigal Pharmaceuticals a Millionaire Maker?
    Via The Motley Fool
    Is Madrigal Pharmaceuticals Stock a Buy?
    Via The Motley Fool
    The Best Biotech Stock to Invest $1,000 in Right Now
    Via The Motley Fool
    Gilead Has A Narrative-Changing Revelation For Its Weight-Loss Contender
    Via Investor's Business Daily
    Thinking of Buying Madrigal Pharmaceuticals Stock? Eli Lilly Would Like to Have a Word.
    Via The Motley Fool
    Where Will Madrigal Pharmaceuticals Be in 3 Years?
    Via The Motley Fool
    Madrigal Pharmaceuticals Stock Earns RS Rating Upgrade
    Via Investor's Business Daily
    10 Health Care Stocks With Whale Alerts In Today's Session
    Via Benzinga
    Better Biotech Stock: Viking Therapeutics vs. Madrigal Pharmaceuticals
    Via The Motley Fool
    What's Going On With Fattly Liver Disease Focused Madrigal Pharmaceuticals, Sagimet Biosciences Shares On Wednesday?
    Via Benzinga
    Madrigal, Akero, 89bio Tumble After Lilly's Weight-Loss Drug Tackles MASH
    Via Investor's Business Daily
    DouYu International Posts Q1 Results, Joins Annexon, Dollar Tree And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
    Via Benzinga
    Viking Therapeutics Stock Crumbles Despite Potential 'Best-In-Class' Liver Disease Drug
    Via Investor's Business Daily
    The Week Ahead: What's Next
    Via Talk Markets
    MDGL Stock Earnings: Madrigal Pharmaceuticals Misses EPS for Q1 2024
    Via InvestorPlace
    12 Health Care Stocks Moving In Tuesday's Pre-Market Session
    Via Benzinga
    10 Health Care Stocks Whale Activity In Today's Session
    Via Benzinga
    6 Stocks Positioned to Soar as Investors Focus on MASH
    Via TheNewswire.com
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.